Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase

Harshini Neelakantan, Hua Yu Wang, Virginia Vance, Jonathan D. Hommel, Stanton F. McHardy, Stanley J. Watowich

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Nicotinamide N-methyltransferase (NNMT) is a fundamental cytosolic biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics. We have identified small molecule inhibitors of NNMT with >1000-fold range of activity and developed comprehensive structure-Activity relationships (SARs) for NNMT inhibitors. Screening of N-methylated quinolinium, isoquinolinium, pyrididium, and benzimidazolium/benzothiazolium analogues resulted in the identification of quinoliniums as a promising scaffold with very low micromolar (IC50 à 1 μM) NNMT inhibition. Computer-based docking of inhibitors to the NNMT substrate (nicotinamide)-binding site produced a robust correlation between ligand-enzyme interaction docking scores and experimentally calculated IC50 values. Predicted binding orientation of the quinolinium analogues revealed selective binding to the NNMT substrate-binding site residues and essential chemical features driving protein-ligand intermolecular interactions and NNMT inhibition. The development of this new series of small molecule NNMT inhibitors direct the future design of lead drug-like inhibitors to treat several metabolic and chronic disease conditions characterized by abnormal NNMT activity.

Original languageEnglish (US)
Pages (from-to)5015-5028
Number of pages14
JournalJournal of Medicinal Chemistry
Volume60
Issue number12
DOIs
StatePublished - Jun 22 2017

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase'. Together they form a unique fingerprint.

  • Cite this